BRIVERA is Brivaracetam, an anti-epileptic medication indicated for the treatment of partial-onset seizures in patients with or without secondary generalization. Brivaracetam displays a high and selective affinity for synaptic vesicle protein 2A (SV2A) in the brain, which may contribute to the anticonvulsant effect.